Description
DT-2216 is a proteolysis targeting chimera degrader which specifically targets Bcl-xL.
Product Unit Size | Cost | Quantity | Stock |
---|
DT-2216 is a proteolysis targeting chimera degrader which specifically targets Bcl-xL.
Cas No. | 2365172-42-3 |
---|---|
Purity | ≥98% |
Formula | C77H96ClF3N10O10S4 |
Formula Wt. | 1542.36 |
IUPAC Name | (2S,4R)-1-[(2S)-2-[[7-[4-[(3R)-3-[4-[[4-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]benzoyl]sulfamoyl]-2-(trifluoromethylsulfonyl)anilino]-4-phenylsulfanylbutyl]piperazin-1-yl]-7-oxoheptanoyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide |
Synonym | DT2216 |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Negi A, Voisin-Chiret A. Strategies to reduce the on-target platelet toxicity of Bcl-xl inhibitors: PROTACs, SNIPERs, and prodrug-based approaches. Chembiochem. 2022 Jun 20;23(12):e202100689. PMID: 35263486
Shebl B, Ng D, Lalazar G, et al. Targeting BCL-XL in fibromellar hepatocellular carcinoma. JCI Insight. 2022 Sep 8;7(17):e161820. PMID: 36073545
Khan S, Wiegand J, Zhang P, et al. BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers. J Hematol Oncol. 2022 Mar 9;15(1):23. PMID: 35260176
Thummuri D, Khan S, Underwood P, et al. Overcoming gemcitabine resistance in pancreatic cancer using the BCL-XL-specific degrader DT2216. Mol Cancer Ther. 2022 Jan;21(1):184-192. PMID: 34667112
Isocitrate dehydrogenase inhibitor.
Nucleotide (guanine) analog, prevents guanine s...
Islet β cell proliferation stimulator.
Macrocyclic lactone.
Produced by various marine proteobacteria
BRD2/4/9 and CECR2 inhibitor.
Spirodihydrobenzofuranlactam
Endogenous peptide hormone, GLP-1 fragment, inv...
5-HT1B/1D agonist.
Alkaloid found in Corydalis; D1 antagonist, org...
Tropane alkaloid found in Solanaceae plants; M1...
Alkaloid found in Securinega; potential GABA-A ...
Antifungal antibiotic
FGFR inhibitor.
Coccidiostat.
VEGFR inhibitor.
NSAID; COX-1/2 and lipoxygenase inhibitor.
ROS1, MET, Ron, Axl, TIE-2, VEGFR2 inhibitor.
Histamine H1 antagonist.
Neuroactive mycotoxin produced by Penicillum an...